Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?
about
Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour.
P2860
Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@ast
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@en
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@nl
type
label
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@ast
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@en
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@nl
prefLabel
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@ast
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@en
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@nl
P2093
P356
P1476
Neoadjuvant therapy for advanc ...... n emerging treatment modality?
@en
P2093
Chrysanthi Aggeli
George N Zografos
Iraklis Perysinakis
P2888
P356
10.14310/HORM.2002.1636
P407
P50
P577
2016-01-01T00:00:00Z
P6179
1067262536